PF-04136309

PF-04136309 · Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-04136309, covering 2016-09-19 to 2019-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients [Phase 2]